Literature DB >> 22460144

CD3 ζ defects in systemic lupus erythematosus.

Tsutomu Takeuchi1, Katsuya Suzuki, Tsuneo Kondo, Keiko Yoshimoto, Kensei Tsuzaka.   

Abstract

The prototype autoimmune disease, systemic lupus erythematosus (SLE), has been known to be associated with deficiency of ζ chain, a component of the T-cell receptor-CD3 complex. Comprehensive analysis has shown that expression of the CD3 ζ chain is attenuated or absent in over half of SLE patients. Furthermore, aberrant transcripts of the CD3 ζ chain, including spliced variants lacking exon 7 or having a short 3'-untranslated region, have been detected in SLE T cells. Although attenuated expression of the CD3 ζ chain is also observed in cancer patients, infections and other autoimmune diseases, sustained attenuation of the CD3 ζ expression accompanied with aberrant transcripts are only observed in SLE. In this study, the authors review the unique features of CD3 ζ defects observed in SLE and discuss the molecular basis of the defects by recent findings in animal models, single-nucleotide polymorphisms and genome-wide association studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460144     DOI: 10.1136/annrheumdis-2011-200641

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  New opportunity for orphan drug development in Japan: Early exploratory clinical trial bases promote drug translation from basic studies to clinical application.

Authors:  Peipei Song; Jianjun Gao; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-05

2.  Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Authors:  M Martins; A H Williams; M Comeau; M Marion; J T Ziegler; B I Freedman; J T Merrill; S B Glenn; J A Kelly; K M Sivils; J A James; J M Guthridge; M E Alarcón-Riquelme; S-C Bae; J-H Kim; D Kim; J-M Anaya; S A Boackle; L A Criswell; R P Kimberly; G S Alarcón; E E Brown; L M Vilá; M A Petri; R Ramsey-Goldman; T B Niewold; B P Tsao; G S Gilkeson; D L Kamen; C O Jacob; A M Stevens; P M Gaffney; J B Harley; C D Langefeld; C Fesel
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

3.  Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.

Authors:  Asif A Dar; Trupti N Pradhan; Dakshayni P Kulkarni; Sagar U Shah; Kanury V Rao; Devendra A Chaukar; Anil K D'Cruz; Shubhada V Chiplunkar
Journal:  Immunology       Date:  2015-12-27       Impact factor: 7.397

4.  Autoimmune rheumatic disease IgG has differential effects upon neutrophil integrin activation that is modulated by the endothelium.

Authors:  Akif A Khawaja; Charis Pericleous; Vera M Ripoll; Joanna C Porter; Ian P Giles
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

5.  MiR-214 regulates CD3ζ expression in T cells.

Authors:  Yankai Xiao; Lixing Guo; Suwen Zhao; Guixuan Huang; Shaohua Chen; Lijian Yang; Yangqiu Li; Bo Li
Journal:  Cent Eur J Immunol       Date:  2019-07-30       Impact factor: 2.085

Review 6.  T cell receptor (TCR) signaling in health and disease.

Authors:  Kinjal Shah; Amr Al-Haidari; Jianmin Sun; Julhash U Kazi
Journal:  Signal Transduct Target Ther       Date:  2021-12-13

7.  Gene expression profiling reveals candidate biomarkers and probable molecular mechanisms in chronic stress.

Authors:  Bohan Zhang; Weijie Zhong; Biao Yang; Yi Li; Shuxian Duan; Junlong Huang; Yanfei Mao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 8.  Disturbed T Cell Signaling and Altered Th17 and Regulatory T Cell Subsets in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Nils Rother; Johan van der Vlag
Journal:  Front Immunol       Date:  2015-11-30       Impact factor: 7.561

9.  Association of CD247 polymorphisms with rheumatoid arthritis: a replication study and a meta-analysis.

Authors:  María Teruel; Cushla McKinney; Alejandro Balsa; Dora Pascual-Salcedo; Luis Rodriguez-Rodriguez; Ana M Ortiz; Carmen Gómez-Vaquero; Miguel A González-Gay; Malcolm Smith; Torsten Witte; Tony Merriman; Benedicte A Lie; Javier Martin
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

10.  Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Kei Ikeda; Yoshie Sanayama; Sohei Makita; Junichi Hosokawa; Mieko Yamagata; Daiki Nakagomi; Katsuhiko Takabayashi; Hiroshi Nakajima
Journal:  Clin Dev Immunol       Date:  2013-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.